Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05211206

IV Fluids and Post-ERCP Pancreatitis

Sponsor: University of Calgary

View on ClinicalTrials.gov

Summary

Aggressive intravenous hydration has been shown in randomized trials to prevent post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP), though studied regimens are often impractical. To date, no studies have prospectively assessed short-term (60-90 minute) aggressive hydration regimens that are feasible for outpatients undergoing ERCP and subsequent discharge. Furthermore, little is known with regard to fluid type, volume, and timing with respect to ERCP. In this study, we will aim to assess whether the amount of peri-procedural intravenous fluid administered around the time of ERCP is associated with the risk of PEP (the primary outcome).

Official title: Association Between Peri-procedural Intravenous Hydration and Post- Endoscopic Retrograde Cholangiopancreatography Pancreatitis

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

13000

Start Date

2022-01-10

Completion Date

2027-06-30

Last Updated

2026-04-29

Healthy Volunteers

Not specified

Conditions

Interventions

OTHER

IV fluids

Amount of intravenous fluids delivered

Locations (1)

Peter Lougheed Hospital

Calgary, Alberta, Canada